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Increasing evidence indicates that epigenetic
changes regulate cell genesis. Here, we ask about
neural precursors, focusing on CREB binding protein
(CBP), a histone acetyltransferase that, when hap-
loinsufficient, causes Rubinstein-Taybi syndrome
(RTS), a genetic disorder with cognitive dysfunction.
We show that neonatal cbp+/ mice are behaviorally
impaired, displaying perturbed vocalization behavior.
cbp haploinsufficiency or genetic knockdown with
siRNAs inhibited differentiation of embryonic cortical
precursors into all three neural lineages, coincident
with decreased CBP binding and histone acetylation
at promoters of neuronal and glial genes. Inhibition of
histone deacetylation rescued these deficits. More-
over, CBP phosphorylation by atypical protein kinase
C z was necessary for histone acetylation at neural
gene promoters and appropriate differentiation.
These data support a model in which environmental
cues regulate CBP activity and histone acetylation
to control neural precursor competency to differen-
tiate, and indicate that cbp haploinsufficiency dis-
rupts this mechanism, thereby likely causing cogni-
tive dysfunction in RTS.
INTRODUCTION
There is increasing interest in the idea that epigenetic changes
regulate the behavior of somatic tissue stem cells (Lunyak and
Rosenfeld, 2008). One epigenetic modification that directly
regulates chromatin structure is histone acetylation, which is
determined by two enzyme classes: the histone deacetylases
(HDACs) (Haberland et al., 2009), and the histone acetyltrans-
ferases (HATs). Of the HATs, two of the best characterized are
CREB binding protein (CBP) and its closely related family
member, p300 (Chan and La Thangue, 2001). CBP is a transcrip-114 Developmental Cell 18, 114–125, January 19, 2010 ª2010 Elsevitional coactivator that interacts with over 300 transcription
factors, and binds to components of the general transcriptional
machinery (Chan and La Thangue, 2001). Intriguingly, CBP and
p300 regulatehematopoietic stemcells (Rebel et al., 2002), raising
the possibility that theymight generally regulate stemcell biology.
Rubinstein-Taybi syndrome (RTS) is a genetic disorder with
cognitive dysfunction, where one allele of CBP is deleted or
mutated (Roelfsema and Peters, 2007). cbp+/ mice display
cognitive dysfunction in adulthood: these perturbations are
attributed to aberrant mature circuit function (Josselyn, 2005).
However, cognitive deficits are evident in early childhood in RTS,
and CBP interacts with developmentally important transcription
factors (Miller and Gauthier-Fisher et al., 2007), suggesting that it
might regulate embryonic neural development.
Here, we examine a potential role for CBP in developing neural
precursors, focusing upon the cerebral cortex, which is gener-
ated from neuroepithelial stem cells that sequentially generate
neurons, astrocytes, and oligodendrocytes (Miller and Gauthier,
2007). We provide evidence that phosphorylation of CBP by
atypical protein kinase C (aPKC) z acts as an epigenetic switch
to promote precursor differentiation, and that cbp haploinsuffi-
ciency perturbs this regulatory mechanism, thereby causing
early cognitive dysfunction in mice as it does in humans.RESULTS
cbp Haploinsufficiency Causes Early Cognitive
Dysfunction in Mice as It Does in Humans
To determine whether cbp+/ mice display early cognitive
dysfunction, we analyzed ultrasonic vocalizations (USVs) in
neonatal mice; alterations in USVs reflect impaired cognition
and social behavior (Branchi et al., 2001). Postnatal Day 10
(P10) mice were transiently isolated from their mothers and
USVs recorded for 4 min immediately after separation. cbp+/
mice were significantly impaired relative to their wild-type litter-
mates; USV numbers and duration were decreased, and USV
peak frequencies increased (Figures 1A and 1B). Thus, neonatal
cbp+/mice are behaviorally impaired, indicating that CBP plays
a role in neural development.er Inc.
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+/+ Figure 1. CBP Is Expressed in the Mouse
Embryonic Cortex and Regulates Neurobe-
havioral Development
(A and B) cbp haploinsufficiency causes early
behavioral deficits in USV. Representative USVs
(A) and graphs (B) showing USV number, duration,
and peak frequency (kHz) in cbp+/ versus cbp+/+
P10 mice following maternal separation (n R 7
each).
(C–J) CBP is expressed in cortical precursors and
newly-born cortical neurons. (C) Western blot for
CBP in E12–P14 cortices. The blot was reprobed
for ERK as a loading control. (D) Immunocyto-
chemistry for CBP (red) in coronal sections of
E12, E15, and E18 cortices showing expression
in the VZ/SVZ next to the ventricle (v) and in the
cortical mantle (CM). (E and F) Immunocytochem-
istry for CBP (red) and bIII-tubulin (E) or nestin (F)
(both green) in the E15 cortical plate (E) or VZ/
SVZ (F). Arrows denote double-labeled cells. (G)
Immunocytochemistry for CBP (red) and bIII-
tubulin (top) or nestin (bottom; both green) in
3 day precursor cultures. Arrows denote double-
labeled cells. (H) Western blot for endogenous
CBP in NIH 3T3 cells transfected with cbp or
scrambled (scr) siRNAs, reprobed for ERK to
ensure equal protein. The graph shows relative
CBP levels determined by densitometry (n = 2). (I)
CBP immunoreactivity (red) in cultured precursors.
The arrow, arrowhead, and asterisk indicate cells
with basal, low, and no detectable CBP, respec-
tively. (J) Quantification of CBP levels as in (I) for
precursors cotransfected with egfp and cbp or
scrambled (scr) siRNAs for 5 days (n = 3 experi-
ments, pooled).
*p < 0.05, **p < 0.01, ***p < 0.001. Scale bars,
100 ([D] left and middle), 250 ([D] right), or 25 mm
(E–G and I). Error bars denote SEM.
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CBP HAT Activity Regulates Neural Cell GenesisCBP Regulates Cortical Precursor Differentiation,
but Not Survival or Proliferation
To determine how CBP regulates neural development, we asked
where it was expressed in the embryonic cortex. Western blots
showed that CBP was expressed throughout embryogenesis,
with levels decreasing postnatally (Figure 1C). Immunocyto-
chemistry of cortical sections from E12 to E18 showed that
CBP was expressed in both nestin-positive precursors of the
VZ/SVZ and bIII-tubulin-positive neurons in the cortical mantle
(Figures 1D–1F). To confirm these data, we immunostained
primary E12–E13 cortical precursor cultures that sequentially
generate neurons and glia (Barnabe´-Heider et al., 2005; Gauth-
ier-Fisher et al., 2007). As seen in vivo, CBP was present in the
nuclei of nestin-positive precursors and bIII-tubulin-positive
neurons (Figure 1G).
Based upon its expression, we sought to determine whether
CBP regulated cortical precursor development by using siRNAs.Developmental Cell 18, 114–125,To test the efficacy of cbp siRNAs, we
transfected them into murine 3T3 cells
and performed Western blots after 3
days; cbp siRNAs decreased endoge-
nous CBP 2-fold, even though only
30%–50% of the cells were transfected
(Figure 1H). We confirmed a similarknockdown in cortical precursors that were cotransfected with
a nuclear EGFP plasmid. Nearly all precursors transfected with
scrambled siRNAs expressed detectable CBP, while most
precursors transfected with cbp siRNAs expressed low or no
detectable CBP (Figures 1I and 1J).
Through theuseof thesesiRNAs,we investigatedwhetherCBP
regulatedcorticalprecursordevelopment, examiningsurvival and
proliferation first. Immunostaining of transfected cells at 2 days
showed that CBP knockdown had no effect on the percentage
of cells expressing Ki67 or cleaved caspase-3, markers of prolif-
eration and apoptosis, respectively (Figures 2A and 2B; see
Figures S1A and S1B available online). CBP knockdown also had
no effect on the percentage of transfected cells with condensed,
apoptotic nuclei (Figure 2C). To determine whether CBP might
instead regulate differentiation, we immunostained cultures for
bIII-tubulin at 5 days; CBP knockdown caused a small but signif-
icant decrease in the number of neurons generated (Figures 2DJanuary 19, 2010 ª2010 Elsevier Inc. 115
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Figure 2. CBP Regulates Differentiation,
but Does Not Affect Survival or Proliferation
of Cortical Precursors
(A–C) Percentage of transfected, Ki67-positive
cells (A), cleaved caspase-3 (CC3)-positive cells
(B), or cells with condensed, apoptotic mor-
phology (C) in precursors cotransfected with
egfp and cbp or scrambled siRNAs for 2 days
(n = 3 experiments each, pooled).
(D) Immunocytochemistry for EGFP (green) and
bIII-tubulin (top), GFAP (middle), or O4 (bottom)
(all red) in precursors cotransfected with egfp
and scrambled siRNAs and cultured in basal
conditions (top), or in CNTF (middle) or neuregulin
b (bottom) for 5 days. Arrows indicate double-
labeled cells.
(E–H) Relative percentage of transfected, bIII-
tubulin-positive neurons (E), GFAP-positive or
CD44-positive astrocytes (F andG), or O4-positive
oligodendrocytes (H) in precursors transfected
with cbp or scrambled siRNAs, as in (D) (n = 3
each, pooled).
(I and J) Percentage of cells that are Ki67 positive
(I) or with apoptotic nuclei (J) in E12 cbp+/+ versus
cbp+/ precursors cultured for 2 days (nR 6 single
embryos each).
(K, M, and N) Immunocytochemistry (red) for bIII
tubulin (K), GFAP (M), or A2B5 (N) in cbp+/+ or
cbp+/ precursors cultured for 3 days (K), or for
5 days in CNTF (M) or neuregulin b (N). Cells
were counterstained with Hoechst 33258 (blue).
Insets show boxed region at higher magnification.
(L, O, and P) Percentage of bIII tubulin-positive
neurons (L), GFAP-positive astrocytes (O), or
A2B5-positive oligodendrocyte precursors (P) in
single-embryo cultures as in (K), (M), and (N),
respectively (nR 5 single embryos each).
*p < 0.05, ***p < 0.001. Scale bars, 13 (D), 100 (K),
or 50 (M and N) mm (see also Figure S1). Error bars
denote SEM.
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CBP HAT Activity Regulates Neural Cell Genesisand 2E). We then investigated gliogenesis, treating cultures for 5
days with either CNTF, which induces astrogenesis (Bonni et al.,
1997), or neuregulinb, which enhancesoligodendrogenesis (Can-
oll et al., 1996). Cultures were immunostained for CD44 or GFAP,
markers of astrocyte precursors and later astrocytes, respec-
tively, or forA2B5andO4,markers of oligodendrocyte precursors
and oligodendrocytes, respectively. Quantification showed that
CBP knockdown decreased the genesis of both astrocytes
(Figures 2D, 2F, and 2G) and oligodendrocytes (Figures 2D and
2H; see Figure 5G for A2B5).
To confirm these findings and to determine their relevance for
RTS, we performed single-embryo cultures with progeny of
cbp+/ crosses, ensuring similar cell densities for all genotypes
(Figure S1C). Immunostaining at 2 days for Ki67, and counter-
staining with Hoechst 33258 to reveal nuclear morphology,
demonstrated that proliferation and survival were similar for
cbp+/+ and cbp+/ cortical precursors (Figures 2I and 2J and116 Developmental Cell 18, 114–125, January 19, 2010 ª2010 ElseviFigure S1C). In contrast, cbp+/ precursors generated fewer
bIII-tubulin neurons at 3 days (Figures 2K and 2L), and fewer
GFAP-positive astrocytes and A2B5-positive oligodendrocyte
precursors after 5 days in CNTF or neuregulin b (Figures 2M–
2P). Thus, CBP globally promotes cortical precursor differentia-
tion, and cbp haploinsufficiency perturbs this function.
CBP Is Essential for Differentiation of Neurons and Glial
Cells in the Embryonic Cortex
To determine if CBP also regulated cortical precursor differenti-
ation in vivo, we performed in utero electroporations at E13/14
with cbp siRNAs and a nuclear EGFP expression plasmid
(Barnabe´-Heider et al., 2005; Bartkowska et al., 2007). When
performed at this age, almost all electroporated cells are
proliferating precursors that generate neurons embryonically
and glia postnatally. Immunostaining 4 days postelectroporation
confirmed the efficacy of the CBP knockdown, with cbp siRNAser Inc.
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Figure 3. Genetic Knockdown of cbp Inhibits Neuro-
genesis and Gliogenesis In Vivo
(A) Confocal image of the VZ/SVZ electroporated with cbp
siRNAs and immunostained for EGFP (green) and CBP
(red). The arrow and arrowhead denote transfected cells
expressing basal or no detectable CBP, respectively.
(B) Quantification of CBP immunoreactivity as in (A) for cells
electroporated with scrambled versus cbp siRNAs.
(C) Confocal image of the VZ/SVZ electroporated with
scrambled siRNA and doubled-labeled for EGFP (green)
and Ki67 (red). Arrows denote double-labeled cells.
(D) Percentage of transfected, Ki67-positive cells in the
VZ/SVZ as in (C) (n =R6 brains each).
(E) Immunocytochemistry for EGFP (green; Hoechst 33258
counterstain is blue) in coronal cortical sections electropo-
rated with scrambled (left panels) or CBP (right panels)
siRNAs. Dotted lines denote the VZ/SVZ and cortical mantle
boundary.
(F) Percentage of EGFP-positive cells within the cortical
mantle as in (E). n = at least 9 brains each.
(G) Confocal image of the cortical plate electroporated with
cbp siRNA and double labeled for EGFP (green) and HuD
(red). Arrows denote a double-labeled cell.
(H) Percentage of total transfected, HuD-positive cells in
cortices as in (G) (nR 5 brains each).
(I) Confocal images of the VZ/SVZ electroporated with
scrambled siRNAs and double-labeled for EGFP (green)
and GFAP (top) or O4 (bottom; both red) at P3. Arrows
denote double-labeled cells.
(J) Percentage of transfected, GFAP-positive (left), or
O4-positive (right) cells in the VZ/SVZ as in (I) (nR 5 brains
each).
(K) Confocal image of the VZ/SVZ electroporated with cbp
siRNAs and doubled labeled for EGFP (green) and Pax6
(red) at E17/18. Arrows denote double-labeled cells.
(L) Percentage of transfected, Pax6-positive cells as in (K)
(nR 5 brains each).
E13/14 cortices were electroporated with egfp and cbp or
scrambled siRNAs and analyzed at E16/17 (C and D), E17/
18 (A, B, E–H, K, and L) or P3 (I and J). *p < 0.05, **p <
0.01. Scale bar, 20 (A, C, G, I, and K) or 250 mm (E). Error
bars denote SEM.
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CBP HAT Activity Regulates Neural Cell Genesisincreasing the percentage of transfected cells expressing little or
no CBP protein (Figures 3A and 3B). CBP knockdown did not
affect cortical precursor survival; at 3 days, only 2–5 cbp or
scrambled siRNA-transfected cells per section expressed
cleaved caspase-3 (data not shown). Similarly, CBP knockdown
did not affect precursor proliferation, as indicated by immunos-
taining for Ki67 at 3 days (Figures 3C and 3D). In contrast,
analysis of electroporated cortices at 4 days demonstrated an
effect on neurogenesis. CBP knockdown decreased both the
percentage of transfected cells that were in the cortical mantle,
the region containing newborn neurons (Figures 3E and 3F),
and the number that expressed the neuron-specific protein,
HuD (Figures 3G and 3H). To investigate whether CBP was
also important for gliogenesis in vivo, we performed our analyses
at P3. Immunostaining for GFAP and O4 demonstrated that cbp
siRNA-electroporated precursors generated many fewer astro-
cytes and oligodendrocytes (Figures 3I and 3J). Since CBP
knockdown inhibits differentiation of neurons and glial cells, we
immunostained for the radial precursor marker, Pax6, at 4 daysDevelopmto determine whether it coincidentally increased precursor
numbers. Quantification indicated that this was indeed the
case (Figures 3K and 3L).
To determine whether these perturbations persisted into
adulthood, we analyzed cbp+/ versus cbp+/+ cortices at P10,
P50, and adulthood, focusing on the corpus callosum, since cal-
losal abnormalities occur in RTS individuals. Measurement of
corpus callosum thickness in Nissl-stained sections at the level
of the rostral hippocampus (Bregma, 1.2 to 2.5; Figure 4A)
demonstrated a 20% reduction in 75% of cbp+/ mice at P10
(Figure 4B), although this difference disappeared by P50 (Fig-
ure 4B). Densitometry of immunostained sections also showed
that, at P10 and P50, 75% and 100%, respectively, of cbp+/
mice showed decreased GFAP immunoreactivity (Figures 4C
and 4D). Consistent with this, chromatin immunoprecipitations
(ChIP) and quantitative real-time PCR (qRT-PCR) demonstrated
that CBP binding to and histone acetylation of the GFAP pro-
moter and, to some degree, the MBP promoter, were decreased
in P50 cbp+/ mice (Figure S2A). In contrast to these persistentental Cell 18, 114–125, January 19, 2010 ª2010 Elsevier Inc. 117
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Figure 4. CBP Binds to and Acetylates Histones at Neural Promoters, and Regulates Corpus Callosum Development
(A–D) cbp haploinsufficiency causes deficits in the corpus callosum. (A) Nissl-stained sections of cbp+/+ and cbp+/ P10 brains. Bars indicate the point at which
corpus callosum thickness was measured. (B) Corpus callosum thickness as in (A) at P10, P50, and in adulthood (3 months to 1 year old); measurements were
normalized to the controls (nR 3 brains each). (C) GFAP immunostaining in sections similar to those in (A). Hatched lines outline the corpus callosum. (D) Quan-
tification by densitometry of GFAP immunoreactivity in the corpus callosum as in (C); measurements were normalized to controls. In (B) and (D), only the 75% of
P10 cbp+/ brains that showed changes were included (nR 3 brains each).
(E–G) CBP binding to and histone acetylation of neural promoters during cortical development. ChIP analysis of a1-tubulin, gfap, mbp, and b-actin promoter
regions for CBP binding (E and G) and for H3K9/14 acetylation (F and G) in E13, E16, P3, or P14 cortices. (E and F) Representative images of gels loaded
with the amplified promoter regions from nonimmunoprecipitated input (I) or from immunoprecipitates with CBP or acetylated H3K9/14 antibodies (A), or with
a control nonimmune IgG (N). (G) The qRT-PCR analysis (mean ± SEM) of the same samples (n = 3 animals/group; significance is relative to other promoters
at the same time point).
(H and I) cbp haploinsufficiency causes decreased promoter binding and decreased histone acetylation during cortical development. ChIP analysis for CBP
binding and H3K9/14 acetylation in E16 (a1-tubulin, GFAP, S100b promoters) or P14 (MBP, PLP2) cbp+/+ versus cbp+/ cortices. (H) Representative images
performed and labeled as in (E) and (F). (I) The qRT-PCR analysis of cbp+/+ and cbp+/ cortices performed as in (G) (n = 3 animals/group).
*p < 0.05, **p < 0.01, ***p < 0.001. Scale bars, 2000 mm (A) and 1220 mm (C) (see also Figure S2). Error bars denote SEM.
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Figure 5. The HDAC Inhibitor, TSA, Rescues the Decreased Cortical
Precursor Differentiation Caused by Genetic Knockdown of CBP
(A) Western blot for H3K9/14 acetylation in cortical precursors treated with
DMSO or TSA in DMSO (20 nM) for 4 days. Blot was reprobed for total H3.
Two of three similar experiments are shown (Exp1 and Exp2).
(B–G) Cortical precursors were cotransfected with egfp and cbp or scrambled
(scr) siRNAs, and TSA at 30 nM (B and C) or 20 nM (D–G) was added 18 hr after
transfection and 6–8 hr before adding CNTF (D and E) or neuregulin b (F and G)
for 4 additional days. (B, D, and F) Immunocytochemistry for EGFP (green) and
bIII-tubulin (B), GFAP (D), or A2B5 (F) (all red) in precursors transfected with
scrambled siRNAs and cultured with DMSO alone (upper panels) or TSA in
DMSO (lower panels). Cells were counterstained with Hoechst 33258 (blue).
Arrows denote double-labeled, transfected cells. Scale bar, 25 mm. (C, E,
and G) Quantification of the percentage of transfected, bIII tubulin-positive
neurons (C), GFAP-positive astrocytes (E), or A2B5-positive oligodendrocyte
precursors (G) in three experiments (pooled) similar to those in (B), (D), and
(F), respectively. *p < 0.05, **p < 0.01. Error bars denote SEM.
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CBP HAT Activity Regulates Neural Cell Genesisperturbations in gliogenesis, no differences in the levels of olfac-
tory bulb neurogenesis were observed in adult male cbp+/
versus cbp+/+ mice (Figure S2B).
CBP Binds to Neuronal and Glial Gene Promoters and
Globally Promotes Histone Acetylation in the Embryonic
Cortex
To investigate whether CBP regulates differentiation by binding
to and acetylating histones at promoters of neural differentiation
genes, we performed ChIP assays. For neurons, we examined
the a1-tubulin promoter, (Gloster et al., 1994), for oligodendro-
cytes, the myelin basic protein (MBP) promoter (Miura et al.,
1989), and for astrocytes, the GFAP promoter (Miura et al.,
1990). As a control, we used the b-actin promoter. Since CBP
interacts with the general transcriptional apparatus, we focused
upon the TATA box regions around these promoters (Fig-
ure S2C). Cross-linked DNA complexes, from cortices ranging
in age from E13 to P14, were immunoprecipitated with anti-
bodies specific for CBP or histone H3 acetylated at lysines 9
and 14 (H3K9/K14) (Weaver et al., 2004, 2005). Analysis of the
uncross-linked, precipitated genomic DNA by semiquantitative
and qRT-PCR demonstrated that CBP bound to all four pro-
moters, with distinct time courses reflective of the genesis of
the three different neural lineages (Figures 4E and 4G). For the
neuronal a1-tubulin promoter, CBP was already bound at E13;
binding peaked at E16, and then decreased postnatally, corre-
lating with neurogenesis (Gloster et al., 1994). For GFAP, CBP
binding peaked from E16 to P3, and decreased by P14, consis-
tent with astrogenesis, while, for MBP, CBP was only bound
postnatally, during the peak of oligodendrocyte maturation. In
contrast, CBP bound the b-actin promoter at equal levels
throughout cortical development (Figure 4E). Interestingly, in all
cases, the relative pattern of H3K9/14 acetylation was similar
to that of CBP binding (Figures 4F and 4G). Two-way ANOVA
analysis of the qRT-PCR data revealed a highly significant
gene 3 age interaction for the promoters with regard to both
CBP (F[2, 24] = 49.62; p = 0.0001) and histone H3K9/K14 acety-
lation (F[3, 23] = 60.32; p < 0.0001).
To determine whether the level of histone acetylation at these
promoters was a function of CBP binding, we isolated cortices
from cbp+/+ versus cbp+/ embryos, and performed ChIP anal-
ysis at E16 for a1-tubulin and GFAP, and at P14 for MBP. We
also analyzed two additional glial promoters: S100b for astro-
cytes, and PLP2 for oligodendrocytes. These experiments
showed decreased CBP binding and decreased H3K9/14
acetylation at all five promoters in CBP+/ cortices (Figures 4H
and 4I). Statistical analyses of the qRT-PCR data indicated
a main effect of genotype (cbp+/+ versus cbp+/ mice: CBP IP,
[F(1, 17) = 334.2; p = 0.0001]; acety-H3K9/14 IP, [F(1, 17) =
124.3; p < 0.0001]), while the interaction of gene with genotype
was nonsignificant for both CBP (F[2, 16] = 1.190; p > 0.05)
and H3K9/14 acetylation (F[2, 16] = 1.078; p > 0.05). Post hoc
analysis indicated significant (p < 0.001) decreases in CBP
binding and histone acetylation of all five promoters in cbp+/
versus cbp+/+ cortices. Thus, cbp haploinsufficiency results in
decreased histone acetylation of neural differentiation genes.
To determine whether the differentiation deficit seen when
CBP was decreased was due to this decreased histone acetyla-
tion, we treated cortical precursors in which CBP was knockedDevelopmdown with the HDAC inhibitor, trichostatin A (TSA) (Yoshida
and Horinouchi, 1999; Weaver et al., 2004, 2005) at a concentra-
tion (20–30 nM) that increased H3K9/K14 acetylation (Fig-
ure 5A), but did not affect survival. Quantification of transfected,
bIII-tubulin-positive neurons at 5 days showed that TSA com-
pletely rescued the decreased neurogenesis seen with CBPental Cell 18, 114–125, January 19, 2010 ª2010 Elsevier Inc. 119
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Figure 6. An aPKC Phosphorylation site on CBP Is Essential for It to Promote Cortical Precursor Differentiation
(A) Western blot of E12 or E17 cortices immunoprecipitated with anti-CBP or control IgG, and probed with an antibody for phosphorylated PKC sites.
(B) Western blots of E12–P4 cortices probed with anti-phosphoS436 CBP and reprobed with anti-CBP.
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CBP HAT Activity Regulates Neural Cell Genesisknockdown (Figures 5B and 5C). A similar rescue of GFAP-posi-
tive astrocytes and A2B5-positive oligodendrocyte precursors
was observed in CNTF or neuregulin b-treated cultures (Figures
5D–5G). Thus, CBP promotes precursor differentiation via his-
tone acetylation.CBP Requires Phosphorylation at an aPKC Site
to Promote Neural Differentiation
To test the idea that the environment might enhance CBP activity
to promote cortical precursor differentiation, we characterized
a CBP serine 436 (S436) phosphorylation site that is downstream
of a receptor tyrosine kinase-aPKC pathway in nonneural cells
(He et al., 2009). CBP was immunoprecipitated from the E12–
E17 cortex, and the immunoprecipitate was probed with an anti-
body that recognizes all phosphorylated PKC consensus sites
(Figure 6A), or with a phospho-specific antibody for the S436
site (Figure 6B). This analysis showed that CBP was phosphory-
lated at PKC sites, including the S436 site, throughout embry-
onic cortical development.
To determine whether CBP S436 phosphorylation had any
functional relevance for cortical precursors, we used plasmids
encoding wild-type cbp or cbp mutants where S436 was
mutated to an aspartate (cbpS436D), making it a phosphomimic,
or to an alanine (cbpS436A), which cannot be phosphorylated
(a phosphomutant) (Figure S3). Cortical precursors were trans-
fected with these constructs and analyzed for survival and prolif-
eration at 2 days, for neurogenesis at 3 days, and for gliogenesis
following treatment with CNTF or neuregulin b for 5 days. None of
these proteins affected cortical precursor survival or proliferation
(Figures 6C and 6D). However, wild-type cbp and the cbp phos-
phomimic, but not the cbp phosphomutant, enhanced differen-
tiation into astrocytes and oligodendrocytes (Figures 6F and
6G). A similar trend was observed for neurogenesis, but this
did not reach significance (Figure 6E). We next performed similar
experiments to determine whether these proteins could rescue
the differentiation deficit seen with cbp+/ precursors. Expres-
sion of wild-type cbp or the cbp phosphomimic completely
rescued the deficits in neurogenesis and gliogenesis seen in
CBP+/ precursors (Figures 6H–6J), while the cbp phosphomu-
tant had no effect (Figures 6H–6J). Thus, CBP must be phos-
phorylated at S436 to promote differentiation.
To investigate the relevance of these findings in vivo, we
utilized mice in which the S436A phosphomutant CBP was
knocked in to the CBP locus. These mice synthesize CBP at
wild-type levels (Zhou et al., 2004). Through the use of ChIP
assays, we determined cortical levels of CBP binding to and
histone acetylation of neural promoters, analyzing the a1-tubulin,
GFAP, and S100b promoters at birth, and the MBP and PLP2
promoters at P14. qRT-PCR demonstrated that CBP binding to(C–G) Precursors were cotransfected with egfp and either wild-type cbp (wt cbp),
for 2 (C and D), 3 (E), or 5 days in CNTF (F) or neuregulin b (G). Graphs show the pe
(G), or displaying apoptotic nuclei (D). In each case, three experiments were poo
(H–J) Single-embryo cbp+/+ or cbp+/ precursor cultures were transfected with e
3 days (H) or treatedwith CNTF (I) or neuregulin b (J) for 5 days. Graphs show perce
results were normalized to wild-type cells with empty vector transfection (in all c
(K and L) Quantification by ChIP assays and real-time PCR (mean ± SEM) of CBP
cbp+/+ or cbpS436A,S436A cortices at P1 (a1-tubulin, GFAP, and S100b promoters
*p < 0.05, **p < 0.01, ***p < 0.001 (see also Figure S3). Error bars denote SEM.
Developmand H3K9/K14 acetylation of these five promoters were
decreased by almost half in cbpS436A,S436A cortices (Figures 6K
and 6L). Statistical analyses of the qRT-PCR data indicated
a main effect of genotype (cbp+/+ versus cbpS436A,S436A mice:
CBP IP, [F(1, 17) = 421.3; p = 0.001]; acety-H3K9/14 IP, [F(1,
17) = 224.6; p < 0.001]), while the interaction of gene with
genotype was nonsignificant for both CBP (F[2, 16] = 1.025;
p > 0.05) and histone H3K9/14 acetylation (F[2, 16] = 1.014;
p > 0.05). Post hoc analysis indicated significant (p < 0.01)
decreases in CBP binding and histone acetylation of all five
promoters in cbpS436A,S436A versus cbp+/+ cortices. Thus, CBP
S436 phosphorylation directly regulates acetylation of his-
tones on neural genes, thereby promoting neural precursor
differentiation.Atypical PKC-Mediated Phosphorylation Is Essential
for CBP-Mediated Differentiation
To determine whether the kinase that phosphorylates the CBP
S436 site to promote differentiation was aPKC, we first deter-
mined which aPKCs are expressed in cortical precursors.
Western blots showed that aPKC i and aPKC z II (also called
aPKM z) were expressed in the embryonic cortex (Figure 7A).
RT-PCR showed that apkc z I was also expressed in cultured
cortical precursors and the embryonic cortex (Figure 7B). To
determine if the CBP S436 site was downstream of aPKC, we
cultured precursors with the general PKC inhibitor, chelerythrine
chloride, a myristoylated peptide pseudosubstrate inhibitor of
aPKCs i/z, or an inhibitor of classical and novel PKCs, Go¨6976.
Western blots showed that chelerythrine chloride and the
aPKC peptide inhibitor, but not Go¨6976, decreased basal CBP
S436 phosphorylation (Figure 7C). We next sought to learn
whether inhibition of aPKC activity would inhibit the increased
differentiation seen with CBP overexpression. Precursors were
transfected with wild-type or phosphomimic CBP, and cultured
for 5 days in CNTF or neuregulin b with one of the three PKC
inhibitors. Chelerythrine chloride and the aPKC peptide inhibitor,
but not Go¨6976, completely blocked the CBP-mediated
increase in astrocytes and oligodendrocytes (Figures 7D–7F).
In contrast, they had no effect on differentiation promoted by
phosphomimic CBP (Figures 7D–7F).
To confirm these results, we used a previously characterized
shRNA for apkc z (He et al., 2009). Precursors were transfected
with EGFP and apkc z shRNA and cultured for 3 days for neuro-
genesis and 5 days in CNTF or neuregulin b for gliogenesis.
Immunostaining showed that aPKC z knockdown decreased
the genesis of GFAP-positive astrocytes (Figure 7G) and A2B5-
positive oligodendrocyte precursors (Figure 7H). The percentage
of bIII-tubulin-positive neurons was also somewhat decreased,
but this did not reach significance (Figure 7I). Consistent withphosphomutant cbp (cbp S436A), phosphomimic cbp (S436D), or empty vector
rcentage of transfected cells expressing Ki67(C), bIII tubulin (E), GFAP (F), A2B5
led.
gfp and wt cbp, cbp S436D, cbp S436A, or the empty vector, and cultured for
ntage of transfected cells positive for bIII tubulin (H), GFAP (I), or A2B5 (J). In (J),
ases, nR 3 individual embryos, pooled).
binding (K) and H3K9/14 acetylation (L) in chromatin immunoprecipitated from
) or P14 (mbp and plp2) (n = 3 animals/group).
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Figure 7. CBP Phosphorylation by aPKC Regulates Cortical Precursor Differentiation
(A) Western blots of E12–P4 cortical tissue for aPKC i, aPKC z, and ERK (as a loading control).
(B) RT-PCR of E12 cortices (Ctx-E12) and E12 precursors cultured 1 day (CP(E12)-1DIV) for PKC z I and II. Cerebellar RNA was a positive control, and no reverse
transcriptase was used (RT) as a negative control.
(C) Western blots for CBP S436 phosphorylation in precursors cultured in CNTF plus 250 nM Go¨6976, 250 nM chelerythrine chloride (CCL), or 2 mM aPKC pseu-
dosubstrate peptide inhibitor for 4 days commencing at 1 day. The blot was reprobed for CBP.
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precursors was increased at 3 days (Figure 7J). Thus, aPKC z
promotes cortical precursor differentiation.
We next investigated whether aPKC z was upstream of CBP
during cortical precursor differentiation, as indicated by the
pseudosubstrate inhibitor experiments (Figures 7E and 7F),
focusing on astrogenesis. Precursors were cotransfected with
wild-type CBP plus scrambled, apkc z, or apkc i shRNAs, and
cultured in the presence of CNTF for 5 days. Immunostaining
for GFAP demonstrated that knockdown of aPKC z, but not
aPKC i, completely rescued the enhanced astrogenesis caused
by CBP overexpression. Thus, aPKC z phosphorylates CBP to
promote cortical precursor differentiation.
DISCUSSION
The data presented here support four major conclusions. First,
the vocalization experiments indicate that, as seen in humans,
cbp haploinsufficiency causes early cognitive deficits in mice.
Some of these deficiencies persist, suggesting that the cognitive
deficits documented in adult mice are at least partially due to
abnormal development. Second, our studieswith genetic knock-
down or haploinsufficiency for cbp indicate that it is required
for normal differentiation of cortical precursors in culture and
in vivo; by binding sequentially to the promoters of neuronal,
astrocytic, and oligodendroglial genes, CBP plays a crucial
role in promoting differentiation into these three neural lineages.
Moreover, CBP binding correlates with histone acetylation at
these genes, and decreased CBP levels cause decreased
histone acetylation. Third, we show that CBP HAT activity is
required for cortical precursor differentiation, since the CBP
knockdown phenotype can be rescued by coincident inhibition
of HDACs. Fourth, we show that phosphorylation by aPKC z is
essential for CBP to bind to neural promoters, to acetylate
histones at those promoters, and to thereby trigger cortical
precursor differentiation.
Based on these data, we propose a model where environ-
mental signals activate aPKC z to phosphorylate CBP S436,
thereby making cortical precursors competent to differentiate.
One way in which CBP phosphorylation might do this is by
directly regulating its HAT activity. A second possibility is that
CBP phosphorylation modulates its interactions with transcrip-
tional regulators, such as occurs in hepatocytes, where phos-
phorylation regulates CBPs interactions with CREB (He et al.,
2009). Potential positive regulators include CBP-interacting
proteins such as neurogenin (Sun et al., 2001), C/EBP (Kovacs
et al., 2003), the STATs (Nakashima et al., 1999), or the olig
bHLH transcription factors (Fukuda et al., 2004), all of which
regulate cortical precursor differentiation (Miller and Gauthier-
Fisher et al., 2007), while negative regulators include the CtBP(D–F) Percentage of transfected, GFAP-positive astrocytes (D and E) or A2B5-pos
wt cbp, cbp S436D, or empty vector, and cultured for 5 days in CNTF (D and E) or
aPKC pseudosubstrate inhibitor (E and F). In each case, four experiments were
(G–J) Percentage of transfected, GFAP-positive astrocytes (G), A2B5-positive oli
radial precursors (J) in cultures cotransfected with egfp and scrambled, or aPKC
Exp1 and Exp2 refer to two independent experiments. In (J), results from three e
(K) Percentage of transfected, GFAP-positive astrocytes in precursors cotransfect
i shRNAs and cultured for 5 days in CNTF. Results of three experiments were po
*p < 0.05, **p < 0.01. Error bars denote SEM.
Developmcorepressors, which bind CBP and regulate neural development
(Senyuk et al., 2005). Regardless of mechanism, our model
predicts that a decrease in phosphorylated CBP, as would occur
in RTS or, potentially, even with some environmental perturba-
tions, would lead to decreased neural cell genesis.
The model presented here provides one way to explain devel-
opmental changes in cortical precursor competence. In the early
cortical neuroepithelium, precursors respond poorly to astro-
genic cues, such as CT-1, and only become fully competent
during the neurogenic period (Miller and Gauthier, 2007). While
this change in competence is necessary to ensure that the
precursor cell pool expands sufficiently, and that gliogenesis
does not occur prematurely, the underlying mechanisms are still
unclear. Histone methylation (Jepsen et al., 2007) and the ATP-
dependent chromatin remodeling factor, Brg-1 (Seo et al.,
2005), have been implicated, and our findings provide an
additional mechanism where environmentally driven CBP phos-
phorylation could determine when a precursor can respond to
gliogenic cues. What are the environmental cues that might
regulate CBP S436 phosphorylation? We show here that aPKCs
are the relevant upstream kinases, and previous work has shown
that aPKC-mediated CBP S436 phosphorylation is downstream
of an insulin-phosphatidylinositol 3-kinase (PI3K) pathway in
hepatocytes (He et al., 2009). Interestingly, a number of growth
factor receptors that activate PI3K and/or aPKC are important
for cortical precursor differentiation, including the Trk neurotro-
phin receptors (Bartkowska et al., 2007), FGFR1 (Song and
Ghosh, 2004), and erbBneuregulin receptors (Canoll et al., 1996).
These studies explain the early cognitive deficits seen in
humanRTSpatients, where about 50%of patients carry amutant
cbp allele (Roelfsema and Peters, 2007). Several RTS mouse
models have been generated in this regard, and all of them
display deficits in adult learning and memory (Josselyn, 2005).
While CBP is clearly important for adult neural circuits (Korzus
et al., 2004), it is also important for neural development, since
RTS individuals show early cognitive dysfunction (Roelfsema
and Peters, 2007) and display neural dysgenesis, including
cortical abnormalities and diminished white matter (Sener,
1995). We show here that cbp+/ mice also display early cogni-
tive abnormalities and corpus callosum perturbations, arguing
that the underlying molecular mechanisms may be similar in
mice and humans.
Together, these findings provide a mechanism whereby envi-
ronmental cues, acting via atypical PKC and CBP, can regulate
stem cell epigenetic status and thereby directly promote
differentiation. While we have studied cortical precursors here,
this mechanism may well generalize to other developing or adult
stem cell populations. Elucidating the environmental signals that
regulate CBP activity, and thus histone acetylation and stem cell
competence, will be an important direction for the future.itive oligodendrocyte precursors (F) in precursors cotransfected with egfp and
neuregulin b (F) plus 100 nMGo¨6976, 100 nM chelerythrine chloride (D), or 1 mM
pooled.
godendrocyte precursors (H), bIII-tubulin-positive neurons (I), or pax6-positive
z shRNA for 3 days (I and J) or 5 days in CNTF (G) or neuregulin b (H). In (G)–(I),
xperiments were pooled.
edwith egfp andwild-type cbp or empty vector plus scrambled, apkc z, or apkc
oled.
ental Cell 18, 114–125, January 19, 2010 ª2010 Elsevier Inc. 123
Developmental Cell
CBP HAT Activity Regulates Neural Cell GenesisEXPERIMENTAL PROCEDURES
Animals
All animal use was approved by the Animal Care Committee for the Hospital
for Sick Children in accordance with the Canadian Council of Animal Care
policies. CD1 mice were obtained from Charles River Laboratory, and
B6.126S6-Crebbptm1Dli mice from The Jackson Laboratory (Kung et al.,
2000), and maintained in the same genetic background. cbp S436A knockin
mice were maintained, bred, and genotyped as previously reported (He
et al., 2009). For olfactory neurogenesis experiments, male cbp+/+ and cbp+/
adult littermates were injected with 5 3 50 mg/ml BrdU at 3 hr intervals, and
killed four weeks later (Kippin et al., 2005).
Cortical Precursor Cell Cultures
CD1 E11.5–E12.5 cortical precursors were cultured as described previously
(Barnabe´-Heider et al., 2005; Gauthier-Fisher et al., 2007). Plating density
was 160,000 cells/ml for single-embryo cultures and plasmid transfections,
and 285,000 cells/ml for siRNA transfections. For gliogenesis experiments,
CNTF or neuregulin b were added 1 day after plating for an additional 4 days.
Transfections, Growth Factors, and Inhibitor Treatments
For siRNAs, precursors were transfected with 80 pmol cbp ON-TARGET plus
SMARTpool siRNAs (proprietary mixture, Dharmacon) or a non-target scram-
bled siRNA pool. siRNAs were mixed with 1 mg of an EF-1a:EGFP plasmid
(pEF-GM) plus 2 ml lipofectamine 2000 in 100 ml Opti-MEM (both from Invitro-
gen), incubated for 45 min, and added to precursors 2 hr after plating. For
plasmids, 1 mg DNA (1:2 ratio of egfp versus cbp plasmids; 1:1:3 ratio of
egfp, apkc shRNA, and cbp plasmids) and 1.5 ml Fugene 6 (Roche) were
mixed with 100 ml Opti-MEM, incubated for 60 min, and added to precursors
2 hr after plating. The mouse cbp constructs and apkc shRNAs were as
previously described (Zhou et al., 2004; He et al., 2009). NIH 3T3 cells and
HEK293 cells were transfected with lipofectamine 2000. CNTF (50 ng/ml;
Cedarlane Laboratories) and neuregulin b (100 ng/ml; R&D Systems) were
added at 24–26 hr. Cells were treated with 20–30 nM TSA (Calbiochem) or
100–250 nM Go¨6976 (Calbiochem), chelerythrine chloride (CCL; Calbio-
chem), or myristoylated aPKC pseudosubstrate peptide inhibitor (Calbio-
chem) were added 18 hr after transfection and 6–8 hr before adding growth
factors.
RT-PCR
cDNA was synthesized from total RNA with the SuperScript Preamplification
System cDNA Synthesis Kit (Invitrogen). Primers and conditions are in Supple-
mental Experimental Procedures.
In Utero Electroporation
In utero electroporation was performed as previously described (Barnabe´-
Heider et al., 2005; Gauthier-Fisher et al., 2009) with E13/E14CD1mice, inject-
ing 4 mg pEF-egfp, 20 pmol siRNAs, and 0.05% Trypan blue.
Immunocytochemistry and Histological Analysis
Immunocytochemistry and Nissl staining were performed as previously
described (Gauthier-Fisher et al., 2007). For BrdU/NeuN colocalization,
sections were incubated in 1 N HCl at 60C after fixation and before blocking,
and sequential immunocytochemistry was performed. Antibodies are in
Supplemental Experimental Procedures.
Microscopy, Confocal Analysis, and Quantification
For precursor cultures, approximately 200 cells per condition in at least
8 randomly chosen fields per experiment were counted. Digital image acqui-
sition was performed with Northern Eclipse software (Empix) with a Sony
XC-75CE CCD video camera. For in utero electroporation, three to four fields
per coronal section from each of five anatomically matched sections per
brain were analyzed on a Zeiss Pascal confocal microscope with the manu-
facturer’s software. A mean of four scans taken with a 403 objective were
computed for each image. For postnatal mice, all studies were blinded,
analyzing three to five coronal sections encompassing the rostral hippo-
campus per brain (Bregma, 1.2 to 2.5). ImageJ software (NIH) was
used to measure corpus callosum thickness from digital images of Nissl-124 Developmental Cell 18, 114–125, January 19, 2010 ª2010 Elsevistained sections acquired with a Mirax slide scanner, or as described above.
For GFAP densitometry, three to four images of each hemisphere (total six to
eight images) were acquired per brain. The corpus callosum was defined by
Hoechst staining, and the GFAP signal thresholded and measured with
Northern Eclipse software. For quantification of adult olfactory neurogenesis,
serial coronal olfactory bulb sections were immunostained for BrdU and
NeuN, and double-labeled cells were counted in every 20th section. Statis-
tical analyses were performed with Student’s t test. In all cases, error bars
indicate SEM.
Western Blot Analysis and Immunoprecipitations
Cells and tissues were lysed in RIPA lysis buffer, 50-100 mg protein lysate run
on SDS-PAGE, and Western blots performed as previously described
(Barnabe´-Heider et al., 2005). For immunoprecipitation, equal amounts of
protein from embryonic cortical lysates were incubated with 15 ml of the
CBP antibody (Santa Cruz Biotechnology) for 1 hr at 4C and then incubated
for the same time period with 30 ml protein A-Sepharose (Sigma). Precipitated
proteins were collected by centrifugation, washed three times with RIPA lysis
buffer, boiled with sample buffer, and loaded on a 7.5% SDS-PAGE gel.
ChIP Assay
ChIP assays were performed as previously described (Weaver et al., 2004,
2005). Embryonic and neonatal cortices were dissected in ice-cold HBSS
buffer, and the chromatin was cross-linked with 1% formaldehyde, sheared
down by sonication, and immunoprecipitated with one of the following: rabbit
polyclonal anti-acetyl-histone H3K9/K14 (Cell Signaling Technology), rabbit
polyclonal anti-CBP (Santa-Cruz Biotechnology), or rabbit nonimmune IgG
antibody (Santa Cruz Biotechnology). One-tenth of the lysate was kept to
quantify DNA before immunoprecipitation (‘‘input’’). Protein-DNA complexes
were un-cross-linked and DNA extracted, precipitated, and resuspended in
13 TE (100 ml). The mouse a1-tubulin (MGI 98869), gfap (MGI 95697), S100b
(MGI 98217), mbp (MGI 96925), plp2 (MGI 1298382), or b-actin (MGI 87904)
TATA box promoter regions of the un-cross-linked DNA was subjected to
real-time qRT-PCR amplification, with primers described in the Supplemental
Experimental Procedures. PCR reactions were done with the FailSafe GREEN
Real-Time PCR Pre-Mix-Choice Kit protocol (Epicenter; InterScience,
Canada), as described in Supplemental Experimental Procedures, with
a LightCycler 480 (Roche Molecular Biochemicals). All reactions were per-
formed in triplicate, and a no-template negative control was included for
each set of primers. No primer-dimers were detected. To calculate fold
change in gene expression, the ratio of the immunoprecipitate/input mean
crossing-point values were determined for each promoter and, where
possible, divided by the same ratio for the b-actin promoter-a region amplified
from the same precipitate. Amplified products were also separated on agarose
gels (2%), and bands were captured with the image acquisition software,
Gene Snap (Synoptics Ltd., USA) on a Syngene Bio Imaging System (Synop-
tics Ltd., USA).
Ultravocalization Test
P10 cbp+/+ and cbp+/ mice were assessed for USV with an Ultrasound
Detector D 1000X (Pettersson Elektronik AB, Uppsala, Sweden) as previously
described (Wang et al., 2008; Supplemental Experimental Procedures). All
testing was carried out under dim red light in a quiet room. Statistical analyses
were performed with two-tailed Student’s t tests.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.devcel.2009.10.023.
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